波兰东南部透析中心维持性血液透析患者的促红细胞生成素治疗——现状

Erythropoietin treatment in patients on maintenance haemodialysis in dialysis centers of South-East region of Poland--present state.

作者信息

Ksiazek A, Majdan M, Jaroszyński A, Swatowski A, Krzywicka A, Kolibska E, Gotner S, Kosicki A, Piaseczny W, Sokalski A

机构信息

Katedra i Klinika Nefrologii Akademii Medycznej, Lublinie.

出版信息

Ann Univ Mariae Curie Sklodowska Med. 1994;48 Suppl 3:1-7.

PMID:8192527

Abstract

South-East region of Poland includes six voivodeships, with about 3.6 mln of inhabitants. Nine dialysis centers work in this region with 273 places to perform maintenance haemodialysis outside Lublin, and 53 places in Lublin Clinic Center. The aim of this paper was to analyse the state of r-Hu EPO treatment in chronic dialysis patients. We would like to compare the treatment possibilities in the clinic unit with other haemodialysis units of our region and with data from Western Europe that we know from EDTA report. Simultaneously we decided to estimate real possibilities of iron treatment monitoring. As it is well known correct management of iron supplementation treatment, allows for the significant reduction of r-Hu EPO administration.

摘要

波兰东南部地区包括六个省，约有360万居民。该地区有九个透析中心，在卢布林以外有273个进行维持性血液透析的床位，在卢布林临床中心有53个床位。本文的目的是分析慢性透析患者重组人促红细胞生成素（r-Hu EPO）治疗的状况。我们希望将临床单位的治疗可能性与本地区其他血液透析单位进行比较，并与我们从欧洲透析移植协会（EDTA）报告中了解到的西欧数据进行比较。同时，我们决定评估铁治疗监测的实际可能性。众所周知，正确管理铁补充治疗可大幅减少r-Hu EPO的使用量。